Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
According to GlobalData, only 24 CRISPR-based drugs are in Phase 2 trials, with 88% of such drugs in earlier-stage or preclinical development.
Altimmune does have a couple of earlier-stage products in its pipeline that are many, many years from any potential commercialization.
Source: https://seekingalpha.com/article/4640109-altimmune-year-of-disappointment?source=feed_all_articles